Phase II Study of Continuous Endostar Infusion Combined With Radiotherapy for the Treatment of Patients With Brain Metastases
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Objective Response Rate (ORR)
1 month after initial treatment
No
Xiaodong Jiang, MD
Principal Investigator
The First People's Hospital of Lianyungang
China:SFDA
Endu-201107
NCT01410370
June 2011
June 2013
Name | Location |
---|